U.S. Physical Therapy, Inc. (NYSE:USPH – Get Free Report) declared a quarterly dividend on Tuesday, November 5th, Wall Street Journal reports. Stockholders of record on Friday, November 15th will be paid a dividend of 0.44 per share on Friday, December 6th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.81%. The ex-dividend date is Friday, November 15th.
U.S. Physical Therapy has increased its dividend payment by an average of 75.2% per year over the last three years. U.S. Physical Therapy has a payout ratio of 60.1% meaning its dividend is sufficiently covered by earnings. Research analysts expect U.S. Physical Therapy to earn $2.95 per share next year, which means the company should continue to be able to cover its $1.76 annual dividend with an expected future payout ratio of 59.7%.
U.S. Physical Therapy Price Performance
USPH traded up $14.46 on Wednesday, reaching $96.99. The stock had a trading volume of 268,577 shares, compared to its average volume of 91,248. The company has a current ratio of 1.88, a quick ratio of 1.88 and a debt-to-equity ratio of 0.28. The company has a market capitalization of $1.46 billion, a price-to-earnings ratio of 77.83, a price-to-earnings-growth ratio of 3.93 and a beta of 1.38. U.S. Physical Therapy has a fifty-two week low of $76.18 and a fifty-two week high of $113.63. The firm has a 50-day moving average of $82.93 and a 200-day moving average of $91.49.
Insiders Place Their Bets
In related news, COO Graham D. Reeve sold 1,724 shares of the business’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total transaction of $142,230.00. Following the transaction, the chief operating officer now owns 7,038 shares in the company, valued at $580,635. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, Director Kathleen A. Gilmartin acquired 2,000 shares of U.S. Physical Therapy stock in a transaction on Tuesday, September 3rd. The stock was purchased at an average price of $86.09 per share, with a total value of $172,180.00. Following the completion of the purchase, the director now owns 18,904 shares of the company’s stock, valued at approximately $1,627,445.36. The trade was a 0.00 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Graham D. Reeve sold 1,724 shares of the business’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the sale, the chief operating officer now owns 7,038 shares of the company’s stock, valued at approximately $580,635. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.70% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
Several brokerages recently commented on USPH. Bank of America reiterated a “neutral” rating and issued a $90.00 target price (down from $114.00) on shares of U.S. Physical Therapy in a report on Monday, October 7th. Barrington Research reiterated an “outperform” rating and set a $108.00 price objective on shares of U.S. Physical Therapy in a research report on Wednesday, October 9th. Finally, StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st.
View Our Latest Stock Analysis on U.S. Physical Therapy
About U.S. Physical Therapy
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Featured Articles
- Five stocks we like better than U.S. Physical Therapy
- How to Find Undervalued Stocks
- What a Trump Win Looks Like for the Market Now and Into 2025
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- What is Put Option Volume?
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.